| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PFE | Common Stock | Sale | $140,448 | -2,800 | -0.61% | $50.16 | 459,904 | 11 Nov 2021 | Direct | |
| transaction | PFE | Common Stock | Sale | $160,288 | -3,200 | -0.7% | $50.09 | 456,704 | 11 Nov 2021 | Direct | |
| transaction | PFE | Common Stock | Sale | $210,126 | -4,200 | -0.92% | $50.03 | 452,504 | 11 Nov 2021 | Direct | |
| transaction | PFE | Common Stock | Sale | $310,372 | -6,200 | -1.4% | $50.06 | 446,304 | 11 Nov 2021 | Direct | |
| transaction | PFE | Common Stock | Sale | $456,274 | -9,100 | -2% | $50.14 | 437,204 | 11 Nov 2021 | Direct | |
| transaction | PFE | Common Stock | Sale | $476,425 | -9,500 | -2.2% | $50.15 | 427,704 | 11 Nov 2021 | Direct | |
| transaction | PFE | Common Stock | Sale | $491,587 | -9,818 | -2.3% | $50.07 | 417,886 | 11 Nov 2021 | Direct | |
| transaction | PFE | Common Stock | Sale | $586,170 | -11,700 | -2.8% | $50.10 | 406,186 | 11 Nov 2021 | Direct | |
| transaction | PFE | Common Stock | Sale | $776,860 | -15,500 | -3.8% | $50.12 | 390,686 | 11 Nov 2021 | Direct | |
| transaction | PFE | Common Stock | Sale | $1,510,604 | -30,200 | -7.7% | $50.02 | 360,486 | 11 Nov 2021 | Direct | |
| transaction | PFE | Common Stock | Sale | $2,389,578 | -47,782 | -13% | $50.01 | 312,704 | 11 Nov 2021 | Direct | |
| holding | PFE | Common Stock | 2,550 | 11 Nov 2021 | By Rule 16b-3 Plan | ||||||
| holding | PFE | Common Stock | 1,621 | 11 Nov 2021 | By Trustee under the Pfizer Share Ownership Plan |